| Literature DB >> 31470815 |
Tobias Braun1, Christian Grüneberg2, Kirsten Süßmilch2,3, Max Wiessmeier2, Isabel Schwenk2, Sarah Eggert2, Annika Machleit-Ebner4, Irene Harras5, Christian Thiel2,6.
Abstract
BACKGROUND: There is inconclusive evidence for the effectiveness of additional exercise in older hospital patients. The aims of this study were (1) to assess the feasibility of an augmented prescribed exercise program (APEP) in older acute medical patients and (2) to measure the potential effects of APEP on mobility capacity in order to assess the feasibility of a large full-scale study.Entities:
Keywords: Exercise therapy; Hospitalization; Mobility limitation; Physiotherapy; Rehabilitation
Mesh:
Year: 2019 PMID: 31470815 PMCID: PMC6716827 DOI: 10.1186/s12877-019-1246-4
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Feasibility outcomes of the study
| Outcome | Description | Operationalization and unit |
|---|---|---|
| Feasibility of the processes and the study design that are key to the success of the main study | ||
| Recruitment rate | Rate between older acute medical inpatients admitted during the study period and study participants | n participants/n inpatients [%] |
| Recruitment time | Time needed to recruit 30 participants | Time [weeks] |
| Refusal rate | Rate between inpatients declining to participate and eligible inpatients | n refusing inpatients/n eligible inpatients [%] |
| Retention rate | Rate between study drop-outs and study participants | n drop-outs/n of participants included [%] |
| Eligibility criteria | Is it obvious who meets and who does not meet the eligibility requirements? | n of unclear cases |
| Are the eligibility criteria sufficient or too restrictive? | Sufficient if recruitment rate > 10% | |
| Randomization | Comparability of randomized groups (blocks of 8 without stratification) | Primary clinical endpoint (de Morton Mobility Index): Assessment of statistical differences between intervention and control group at baseline (2-sided t-test) |
| Feasibility of the outcome measures | ||
| Safety | Number of adverse events during study assessments | Total n |
| Duration | Length of time to fill out all the study forms | Time in minutes; number (rate) of assessment sessions completed within one single session |
| Acceptance | Number of refused outcome measures | Total n |
| Completeness | Number of missing items per outcome measure | Total n |
| Interpretability | floor or ceiling effects | ≥15% of participants are not able to perform an outcome measure; ≥15% of participants score the lowest or highest score of a scale |
| Resource problems that can occur during the main study | ||
| Equipment | Is the equipment readily available when and where it is needed? | Number of issues with assessment equipment, such as break downs, shortage of equipment |
| Center willingness and capacity | Do the clinical centers do what they committed to do? | Number of issues with workflows; number of capacity issues |
| Feasibility and acceptability of the APEP intervention and adherence to the exercise protocol | ||
| Amount | Frequency | n of sessions per participant; mean n of sessions per weak |
| Duration | Mean duration of sessions [min] | |
| Compliance | Rate of scheduled and completed sessions | N sessions completed / n sessions scheduled (%) |
| Intensity | Participant’s subjective rating of perceived exertion assessed | Mean perceived exertion after each session [BORG scale score] |
| (Non)compliance or adherence rate | Rate between intervention group participants who perform at least 75% of planned APEP intervention sessions and all intervention group participants | n of intervention group participants who perform at least 75% of planned APEP intervention sessions/n intervention group participants [%] |
| Safety | Adverse events (moderate, or severe) caused not, probably caused, likely caused or surely caused by the intervention | Total n |
| Acceptability | Motivation | Mean motivation of participant’s to perform additional physiotherapy sessions (APEP) [numeric rating scale score; 0–10 points] |
| Recovery | Mean participant’s recovery prior to additional physiotherapy sessions (APEP) [numeric rating scale score; 0–10 points] | |
| Costs | Delivery of APEP intervention | Costs [€] for all actually planned and delivered APEP sessions |
Abbreviations: n = number, APEP = augmented prescribed exercise program
Outcome measures used in the study
| Domain | Outcome measure | Scale range | Metric | ORO | PRO | Baseline | Follow-up |
|---|---|---|---|---|---|---|---|
| Mobility | de Morton Mobility Index | 0–100 points | ratio | X | X | X | |
| Gait speed | ratio [m/s] | ratio | X | X | X | ||
| Hierarchical Assessment of Balance and Mobility | 0–26 points | ratio | X | X | X | ||
| Timed up and go test | ratio [s] | ratio | X | X | X | ||
| Walking ability | Functional Ambulation Categories | 0–5 points | ordinal | X | X | X | |
| Physical endurance | 6-min walk test | ratio [m] | ratio | X | X | X | |
| Frailty | Frailty Index | 0–1 points | ratio | X | X | X | X |
| Falls efficacy | Falls Efficacy Scale – International | 16–64 points | ordinal | X | X | X | |
| Multimorbidity | Number of comorbidities | ratio [n] | ratio | X | X | ||
| Disability | Barthel Index | 0–100 points | ordinal | X | X | ||
| Cognition | Mini Mental State Examination | 0–30 points | ordinal | X | X | ||
| Length of stay | Length of stay | Ratio [days] | ratio | X |
ORO = observer-rated outcome (performance-based), PRO = patient-reported outcome, m = meter, s = seconds, n = number
Fig. 1Participants’ flow through the trial
Demographic and clinical characteristics of the study participants at baseline
| Characteristic | Intervention group (n = 17) | Control group (n = 18) |
|---|---|---|
| Age, years | 78.6 ± 7.5 | 83.1 ± 7.4 |
| Sex, female, n (%) | 13 (76%) | 13 (72%) |
| Mini-Mental State Examination, 0–30 points | 25.7 ± 3.0 | 26.4 ± 2.8 |
| Barthel Index, 0–100 points | 62.9 ± 13.9 | 58.3 ± 17.2 |
| Comorbidities, median (IQR) | 2 (0–4) | 2.5 (2–3.25) |
| Multimorbidity (≥2 comorbidities), n (%) | 10 (59%) | 15 (83%) |
| Time admission to baseline, days | 2.4 ± 1.4 | 2.3 ± 1.3 |
| Time baseline to follow-up, days | 12.4 ± 2.6a | 12.5 ± 2.1b |
| Time follow-up to discharge, days | 3.7 ± 2.8 | 3.8 ± 1.7 |
| Primary diagnosis according to ICD-10 | ||
| IV Endocrine, nutritional and metabolic diseases, n (%) | 0 | 2 (11%) |
| VI Diseases of the nervous system, n (%) | 3 (18%) | 1 (6%) |
| IX Circulatory, n (%) | 3 (18%) | 3 (17%) |
| X Respiratory, n (%) | 0 | 3 (17%) |
| XI Digestive system, n (%) | 1 (6%) | 0 |
| XIII Musculoskeletal, n (%) | 7 (41%) | 5 (28%) |
| XVIII Symptoms, signs and abnormal clinical and laboratory findings, n (%) | 2 (12%) | 4 (22%) |
| XIX Injury, poisoning and certain other consequences of external causes, n (%) | 1 (6%) | 0 |
| Functional Ambulation Category, median (IQR) | 4 (3–4) | 4 (3–4) |
| 3, n (%) | 5 (29%) | 7 (39%) |
| 4, n (%) | 12 (71%) | 10 (56%) |
| 5, n (%) | 0 | 1 (6%) |
| Walking aid | ||
| None, n (%) | 2 (12%) | 4 (22%) |
| Wheeled-walker/rollator, n (%) | 14 (82%) | 13 (72%) |
| Cane/single crutch, n (%) | 1 (6%) | 1 (6%) |
Abbreviations: IQR = interquartile range, ICD-10 = 10th revision of the International Statistical Classification of Diseases and Related Health Problems
Data are mean ± standard deviation unless stated otherwise
a n = 16 b n = 12
Fig. 2Distribution of de Morton Mobility Index scores
Fig. 3Overview of augmented prescribed exercise program (APEP) sessions with reasons for non-adherence and for abandonment
Fig. 4Number of scheduled and performed augmented prescribed exercise program (APEP) sessions per participant according to the duration of each participant’s individual intervention period. Participant #119 withdrew from the study without performing any APEP session or the follow-up assessment
Motivation, recovery, perceived physical exertion and duration of the APEP sessions
| n sessions | Median | |
|---|---|---|
| Motivation prior to each APEP session (0–10 points) | 89 | 8 (IQR: 5.8–8), range: 0–10 |
| Recovery prior to each APEP session (0–10 points) | 89 | 6 (IQR: 5–8), range: 0–10 |
| BORG scale (6–20 points) | 83 | 14 (IQR: 12–15), range: 8–20 |
| Duration of APEP sessions | 90 | 22.5 (IQR: 20–25), range: 14–30 |
Abbreviations: n = number, IQR = interquartile range, APEP = augmented prescribed exercise program
Unadjusted and adjusted mean between-group differences in the primary and secondary outcomes
| Outcome measure | Intervention group, n = 17 | Control group, n = 18 | Unadjusted between-group differences | Adjusted between-group differences* | ES | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Follow-up | Change | Baseline | Follow-up | Change | mean (95% CI) | p | mean (95% CI) | p | ||
| DEMMI, mean (SD) | 49.4 (16.0) | 57.2 (17.0) | 7.8 (12.7) | 52.9 (11.1) | 55.7 (11.3) | 2.8 (9.1) | 5.0 (−2.5 to 12.6) | 0.18 | 4.1 (0.4 to 7.8) | 0.26 | 0.45 |
| HABAM, mean (SD) | 19.1 (4.7) | 20.3 (4.9) | 1.2 (3.5) | 19.9 (4.4) | 20.9 (4.0) | 1.0 (2.1) | 0.2 (−1.8 to 2.2) | 0.86 | 0 (−0.9 to 0.9) | 0.99 | 0.07 |
| TUG, mean (SD) | 28.6 (13.2) | 22.8 (12.2) | −5.8 (6.6) | 24.9 (11.1) | 22.4 (9.5) | −2.5 (5.9) | 3.3 (−1.0 to 7.6) | 0.13 | 2.5 (0.4 to 4.6) | 0.21 | 0.53 |
| Gait speed, mean (SD) | 0.53 (0.17) | 0.65 (0.20) | 0.12 (0.20) | 0.60 (0.19) | 0.64 (0.28) | 0.04 (0.15) | 0.07 (−0.05 to 0.19) | 0.22 | 0.07 (0.01 to 0.13) | 0.25 | 0.45 |
| 6-min walk test, mean (SD) | 154.5 (59.6) | 194.9 (85.8) | 40.4 (80.9) | 167.7 (79.4) | 170.8 (79.9) | 3.1 (37.7) | 37.4 (−5.6 to 80.4) | 0.09 | 34.7 (13.7 to 55.7) | 0.11 | 0.60 |
| Frailty Index, mean (SD) | 0.46 (0.20) | 0.40 (0.19) | −0.05 (0.12) | 0.46 (0.14) | 0.41 (0.15) | −0.04 (0.08) | 0.01 (−0.06 to 0.08) | 0.72 | 0.01 (−0.02 to 0.05) | 0.72 | 0.01 |
| FES-I, median (IQR) | 31 (22–57) | 30 (22–52) | 0 (−7–5) | 31 (26–45) | 31 (25–46) | 0 (−4–4) | 2.4 (− 5.5 to 10.3) | 0.92 | # | # | 0.01 |
| FAC, median (IQR) | 4 (3–4) | 4 (4–4) | 0 (0–0) | 4 (3–4) | 4 (3–4) | 0 (0–0) | 0 (− 0.4 to 0.4) | 0.81 | # | # | 0.04 |
Abbreviations: n = number, ES = effect size, CI = confidence interval, IQR = interquartile range, DEMMI = de Morton Mobility Index, HABAM = Hierarchical Assessment of Balance and Mobility, TUG = timed up and go test, FES-I = Falls Efficacy Scale – International, FAC = Functional Ambulation Categories
*Adjusted for baseline values of the respective outcome measure